{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:53:11Z","timestamp":1788252791636,"version":"build-2803163510"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T00:00:00Z","timestamp":1709337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Rev and Rep"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1007\/s12015-024-10697-4","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T04:02:08Z","timestamp":1709352128000},"page":"1200-1212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Advances in Treatments for Epidermolysis Bullosa (EB): Emphasis on Stem Cell-Based Therapy"],"prefix":"10.1007","volume":"20","author":[{"given":"Ramin","family":"Raoufinia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid reza","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neda","family":"Keyhanvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meysam","family":"Moghbeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Abdyazdani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karim","family":"Naghipoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Forouzanfar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Foroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1679-1068","authenticated-orcid":false,"given":"Ehsan","family":"Saburi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,2]]},"reference":[{"issue":"1","key":"10697_CR1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1038\/s41572-020-0210-0","volume":"6","author":"A Bardhan","year":"2020","unstructured":"Bardhan, A., Bruckner-Tuderman, L., Chapple, I. L. C., Fine, J. D., Harper, N., Has, C., et al. (2020). Epidermolysis Bullosa. Nature Reviews Disease Primers, 6(1), 78.","journal-title":"Nature Reviews Disease Primers"},{"issue":"5","key":"10697_CR2","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1016\/j.jid.2017.12.016","volume":"138","author":"J Uitto","year":"2018","unstructured":"Uitto, J., Bruckner-Tuderman, L., McGrath, J. A., Riedl, R., & Robinson, C. (2018). EB2017\u2014progress in epidermolysis bullosa research toward treatment and cure. Journal of Investigative Dermatology, 138(5), 1010\u20131016.","journal-title":"Journal of Investigative Dermatology"},{"issue":"7","key":"10697_CR3","doi-asserted-by":"publisher","first-page":"e438","DOI":"10.1542\/neo.22-7-e438","volume":"22","author":"AW Lucky","year":"2021","unstructured":"Lucky, A. W., Whalen, J., Rowe, S., Marathe, K. S., & Gorell, E. (2021). Diagnosis and care of the newborn with epidermolysis bullosa. Neoreviews, 22(7), e438\u2013e51.","journal-title":"Neoreviews"},{"key":"10697_CR4","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1016\/j.abd.2020.05.001","volume":"95","author":"LM Mariath","year":"2020","unstructured":"Mariath, L. M., Santin, J. T., Schuler-Faccini, L., & Kiszewski, A. E. (2020). Inherited epidermolysis bullosa: Update on the clinical and genetic aspects. Anais brasileiros de dermatologia, 95, 551\u2013569.","journal-title":"Anais brasileiros de dermatologia"},{"key":"10697_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-019-1279-y","volume":"15","author":"AL Bruckner","year":"2020","unstructured":"Bruckner, A. L., Losow, M., Wisk, J., Patel, N., Reha, A., Lagast, H., et al. (2020). The challenges of living with and managing Epidermolysis Bullosa: Insights from patients and caregivers. Orphanet Journal of rare Diseases, 15, 1\u201314.","journal-title":"Orphanet Journal of rare Diseases"},{"issue":"10","key":"10697_CR6","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1111\/exd.13979","volume":"28","author":"C Prodinger","year":"2019","unstructured":"Prodinger, C., Reichelt, J., Bauer, J. W., & Laimer, M. (2019). Epidermolysis bullosa: Advances in research and treatment. Experimental Dermatology, 28(10), 1176\u20131189.","journal-title":"Experimental Dermatology"},{"issue":"4","key":"10697_CR7","doi-asserted-by":"publisher","first-page":"a041229","DOI":"10.1101\/cshperspect.a041229","volume":"15","author":"L De Rosa","year":"2023","unstructured":"De Rosa, L., Enzo, E., Palamenghi, M., Sercia, L., & De Luca, M. (2023). Stairways to Advanced therapies for Epidermolysis Bullosa. Cold Spring Harbor Perspectives in Biology, 15(4), a041229.","journal-title":"Cold Spring Harbor Perspectives in Biology"},{"key":"10697_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.gene.2019.01.037","volume":"694","author":"A Mirzaei","year":"2019","unstructured":"Mirzaei, A., Saburi, E., Islami, M., Ardeshirylajimi, A., Omrani, M. D., Taheri, M., et al. (2019). Bladder smooth muscle cell differentiation of the human induced pluripotent stem cells on electrospun poly(lactide-co-glycolide) nanofibrous structure. Gene, 694, 26\u201332.","journal-title":"Gene"},{"issue":"4","key":"10697_CR9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.3390\/bioengineering10040422","volume":"10","author":"A Niti","year":"2023","unstructured":"Niti, A., Koliakos, G., & Michopoulou, A. (2023). Stem cell therapies for Epidermolysis Bullosa Treatment. Bioengineering, 10(4), 422.","journal-title":"Bioengineering"},{"key":"10697_CR10","doi-asserted-by":"crossref","unstructured":"Koller, U. (2023). Gene therapy advances shine the spotlight on Epidermolysis Bullosa, bringing hope to patients. Molecular Therapy.","DOI":"10.1016\/j.ymthe.2023.06.002"},{"issue":"4","key":"10697_CR11","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/bjd.20910","volume":"186","author":"K Subramaniam","year":"2022","unstructured":"Subramaniam, K., Antoniou, M., McGrath, J., & Lwin, S. (2022). The potential of gene therapy for recessive dystrophic epidermolysis bullosa. British Journal of Dermatology, 186(4), 609\u2013619.","journal-title":"British Journal of Dermatology"},{"issue":"4","key":"10697_CR12","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1111\/jdv.17012","volume":"35","author":"R Baardman","year":"2021","unstructured":"Baardman, R., Yenamandra, V. K., Duipmans, J. C., Pasmooij, A. M. G., Jonkman, M. F., van den Akker, P. C., et al. (2021). Novel insights into the epidemiology of epidermolysis bullosa (EB) from the Dutch EB Registry: EB more common than previously assumed? Journal of the European Academy of Dermatology and Venereology: JEADV, 35(4), 995\u20131006.","journal-title":"Journal of the European Academy of Dermatology and Venereology: JEADV"},{"issue":"11","key":"10697_CR13","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1001\/jamadermatol.2016.2473","volume":"152","author":"JD Fine","year":"2016","unstructured":"Fine, J. D. (2016). Epidemiology of inherited epidermolysis bullosa based on incidence and prevalence estimates from the National Epidermolysis Bullosa Registry. JAMA Dermatology, 152(11), 1231\u20131238.","journal-title":"JAMA Dermatology"},{"key":"10697_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.trsl.2015.05.008","volume":"168","author":"C Perdoni","year":"2016","unstructured":"Perdoni, C., Osborn, M. J., & Tolar, J. (2016). Gene editing toward the use of autologous therapies in recessive dystrophic epidermolysis bullosa. Translational Research: The Journal of Laboratory and Clinical Medicine, 168, 50\u201358.","journal-title":"Translational Research: The Journal of Laboratory and Clinical Medicine"},{"issue":"5","key":"10697_CR15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/bjd.20958","volume":"186","author":"G Petrof","year":"2022","unstructured":"Petrof, G., Papanikolaou, M., Martinez, A. E., Mellerio, J. E., McGrath, J. A., Bardhan, A., et al. (2022). The epidemiology of epidermolysis bullosa in England and Wales: Data from the national epidermolysis bullosa database. British Journal of Dermatology, 186(5), 843\u2013848.","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"10697_CR16","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1001\/archdermatol.2010.109","volume":"146","author":"YC Kho","year":"2010","unstructured":"Kho, Y. C., Rhodes, L. M., Robertson, S. J., Su, J., Varigos, G., Robertson, I., et al. (2010). Epidemiology of epidermolysis bullosa in the antipodes: The Australasian Epidermolysis Bullosa Registry with a focus on Herlitz junctional epidermolysis bullosa. Archives of Dermatology, 146(6), 635\u2013640.","journal-title":"Archives of Dermatology"},{"key":"10697_CR17","doi-asserted-by":"crossref","unstructured":"Watkins, J. Diagnosis, treatment and management of epidermolysis bullosa. British journal of nursing (Mark Allen Publishing). 2016 Apr 28-May 11;25(8):428\u2009\u2013\u200931.","DOI":"10.12968\/bjon.2016.25.8.428"},{"issue":"3","key":"10697_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/j.1346-8138.2009.00800.x","volume":"37","author":"D Sawamura","year":"2010","unstructured":"Sawamura, D., Nakano, H., & Matsuzaki, Y. (2010). Overview of epidermolysis bullosa. The Journal of Dermatology, 37(3), 214\u2013219.","journal-title":"The Journal of Dermatology"},{"issue":"8","key":"10697_CR19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1046\/j.1365-2230.2002.01121.x","volume":"27","author":"HM Horn","year":"2002","unstructured":"Horn, H. M., & Tidman, M. J. (2002). Quality of life in Epidermolysis Bullosa. Clinical and Experimental Dermatology, 27(8), 707\u2013710.","journal-title":"Clinical and Experimental Dermatology"},{"issue":"5","key":"10697_CR20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.ad.2015.01.007","volume":"106","author":"F Larcher","year":"2015","unstructured":"Larcher, F., & Del R\u00edo, M. (2015). Innovative therapeutic strategies for recessive dystrophic epidermolysis bullosa. Actas dermo-sifiliograficas, 106(5), 376\u2013382.","journal-title":"Actas dermo-sifiliograficas"},{"issue":"3","key":"10697_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jdermsci.2021.11.004","volume":"104","author":"K Natsuga","year":"2021","unstructured":"Natsuga, K., Shinkuma, S., Hsu, C. K., Fujita, Y., Ishiko, A., Tamai, K., et al. (2021). Current topics in Epidermolysis bullosa: Pathophysiology and therapeutic challenges. Journal of Dermatological Science, 104(3), 164\u2013176.","journal-title":"Journal of Dermatological Science"},{"issue":"4","key":"10697_CR22","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/bjd.17619","volume":"180","author":"AE Martinez","year":"2019","unstructured":"Martinez, A. E. (2019). Time to drop the stigma: Cannabinoids are drugs that may alleviate pain in people with epidermolysis bullosa. The British Journal of Dermatology, 180(4), 711\u2013712.","journal-title":"The British Journal of Dermatology"},{"issue":"8","key":"10697_CR23","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1517\/13543784.16.8.1267","volume":"16","author":"E Rallis","year":"2007","unstructured":"Rallis, E., Korfitis, C., Gregoriou, S., & Rigopoulos, D. (2007). Assigning new roles to topical tacrolimus. Expert Opinion on Investigational Drugs, 16(8), 1267\u20131276.","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10697_CR24","doi-asserted-by":"crossref","unstructured":"Danial, C., Adeduntan, R., Gorell, E. S., Lucky, A. W., Paller, A. S., Bruckner, A. L. (2015). Evaluation of Treatments for Pruritus in Epidermolysis Bullosa. Pediatric dermatology. Sep-Oct;32(5):628\u2009\u2013\u200934.","DOI":"10.1111\/pde.12486"},{"issue":"12","key":"10697_CR25","doi-asserted-by":"publisher","first-page":"8925","DOI":"10.1002\/jcp.29737","volume":"235","author":"H Atabati","year":"2020","unstructured":"Atabati, H., Esmaeili, S. A., Saburi, E., Akhlaghi, M., Raoofi, A., Rezaei, N., et al. (2020). Probiotics with ameliorating effects on the severity of skin inflammation in psoriasis: Evidence from experimental and clinical studies. J Cell Physiol [Review], 235(12), 8925\u20138937.","journal-title":"J Cell Physiol [Review]"},{"key":"10697_CR26","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/1750-1172-9-76","volume":"9","author":"M El Hachem","year":"2014","unstructured":"El Hachem, M., Zambruno, G., Bourdon-Lanoy, E., Ciasulli, A., Buisson, C., Hadj-Rabia, S., et al. (2014). Multicentre consensus recommendations for skin care in inherited epidermolysis bullosa. Orphanet Journal of Rare Diseases, 9, 76.","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"2","key":"10697_CR27","first-page":"343","volume":"39","author":"S Salera","year":"2020","unstructured":"Salera, S., Tadini, G., Rossetti, D., Grassi, F. S., Marchisio, P., Agostoni, C., et al. (2020). A nutrition-based approach to epidermolysis bullosa: Causes, assessments, requirements and management. Clinical nutrition (Edinburgh. Scotland), 39(2), 343\u2013352.","journal-title":"Scotland)"},{"issue":"2","key":"10697_CR28","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.bbmt.2013.11.001","volume":"20","author":"J Kurtzberg","year":"2014","unstructured":"Kurtzberg, J., Prockop, S., Teira, P., Bittencourt, H., Lewis, V., Chan, K. W., et al. (2014). Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. Biology of Blood and Marrow Transplantation, 20(2), 229\u2013235.","journal-title":"Biology of Blood and Marrow Transplantation"},{"issue":"1","key":"10697_CR29","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s13287-022-02920-1","volume":"13","author":"N Kaffash Farkhad","year":"2022","unstructured":"Kaffash Farkhad, N., Sedaghat, A., Reihani, H., Adhami Moghadam, A., Bagheri Moghadam, A., Khadem Ghaebi, N., et al. (2022). Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: A successful phase 1, control-placebo group, clinical trial. Stem Cell Research & Therapy, 13(1), 283.","journal-title":"Stem Cell Research & Therapy"},{"key":"10697_CR30","unstructured":"Farkhad, N. K., Sedaghat, A., Reihani, H., Moghadam, A. A., Moghadam, A. B., Ghaebi, N. K. (2022). Specific clinical and immunological changes following mesenchymal stem cell transplantation in COVID-19\u2013induced acute respiratory distress syndrome patients: A phase-I clinical trial. Iranian Journal of Allergy Asthma and Immunology. :1\u201317."},{"key":"10697_CR31","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.reth.2022.03.006","volume":"20","author":"NK Farkhad","year":"2022","unstructured":"Farkhad, N. K., Mahmoudi, A., & Mahdipour, E. (2022). Regenerative therapy by using mesenchymal stem cells-derived exosomes in COVID-19 treatment. The potential role and underlying mechanisms. Regenerative Therapy, 20, 61\u201371.","journal-title":"Regenerative Therapy"},{"key":"10697_CR32","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.reth.2021.07.006","volume":"18","author":"J Tavakol-Afshari","year":"2021","unstructured":"Tavakol-Afshari, J., Boroumand, A. R., Farkhad, N. K., Moghadam, A. A., Sahab-Negah, S., & Gorji, A. (2021). Safety and efficacy of bone marrow derived-mesenchymal stem cells transplantation in patients with amyotrophic lateral sclerosis. Regenerative Therapy, 18, 268\u2013274.","journal-title":"Regenerative Therapy"},{"issue":"8","key":"10697_CR33","first-page":"872","volume":"26","author":"S Najafi","year":"2023","unstructured":"Najafi, S., Najafi, P., Kaffash Farkhad, N., Hosseini Torshizi, G., Assaran Darban, R., Boroumand, A. R., et al. (2023). Mesenchymal stem cell therapy in amyotrophic lateral sclerosis (ALS) patients: A comprehensive review of disease information and future perspectives. Iranian Journal of Basic Medical Sciences, 26(8), 872\u2013881.","journal-title":"Iranian Journal of Basic Medical Sciences"},{"issue":"7","key":"10697_CR34","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1056\/NEJMoa0910501","volume":"363","author":"JE Wagner","year":"2010","unstructured":"Wagner, J. E., Ishida-Yamamoto, A., McGrath, J. A., Hordinsky, M., Keene, D. R., Woodley, D. T., et al. (2010). Bone marrow transplantation for recessive dystrophic epidermolysis bullosa. The New England Journal of Medicine, 363(7), 629\u2013639.","journal-title":"The New England Journal of Medicine"},{"issue":"3","key":"10697_CR35","doi-asserted-by":"publisher","first-page":"429","DOI":"10.3109\/14653241003587637","volume":"12","author":"P Conget","year":"2010","unstructured":"Conget, P., Rodriguez, F., Kramer, S., Allers, C., Simon, V., Palisson, F., et al. (2010). Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa. Cytotherapy, 12(3), 429\u2013431.","journal-title":"Cytotherapy"},{"issue":"2","key":"10697_CR36","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/dth.12305","volume":"29","author":"M El-Darouti","year":"2016","unstructured":"El-Darouti, M., Fawzy, M., Amin, I., Abdel Hay, R., Hegazy, R., Gabr, H., et al. (2016). Treatment of dystrophic epidermolysis bullosa with bone marrow non\u2010hematopoeitic stem cells: A randomized controlled trial. Dermatologic Therapy, 29(2), 96\u2013100.","journal-title":"Dermatologic Therapy"},{"issue":"9899","key":"10697_CR37","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(13)61897-8","volume":"382","author":"J Tolar","year":"2013","unstructured":"Tolar, J., & Wagner, J. E. (2013). Allogeneic blood and bone marrow cells for the treatment of severe epidermolysis bullosa: Repair of the extracellular matrix. Lancet (London England), 382(9899), 1214\u20131223.","journal-title":"Lancet (London England)"},{"issue":"9","key":"10697_CR38","doi-asserted-by":"publisher","first-page":"2319","DOI":"10.1038\/jid.2015.158","volume":"135","author":"G Petrof","year":"2015","unstructured":"Petrof, G., Lwin, S. M., Martinez-Queipo, M., Abdul-Wahab, A., Tso, S., Mellerio, J. E., et al. (2015). Potential of systemic allogeneic mesenchymal stromal cell therapy for children with recessive dystrophic epidermolysis bullosa. The Journal of Investigative Dermatology, 135(9), 2319.","journal-title":"The Journal of Investigative Dermatology"},{"issue":"3","key":"10697_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phoj.2019.09.002","volume":"4","author":"V Khandelwal","year":"2019","unstructured":"Khandelwal, V., Choudhary, D., Sharma, S. K., & Doval, D. (2019). Bone marrow transplant for recessive dystrophic epidermolysis bullosa. Pediatric Hematology Oncology Journal, 4(3), 74\u201376.","journal-title":"Pediatric Hematology Oncology Journal"},{"issue":"2","key":"10697_CR40","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.jaad.2019.11.038","volume":"83","author":"E Rashidghamat","year":"2020","unstructured":"Rashidghamat, E., Kadiyirire, T., Ayis, S., Petrof, G., Liu, L., Pullabhatla, V., et al. (2020). Phase I\/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa. Journal of the American Academy of Dermatology, 83(2), 447\u2013454.","journal-title":"Journal of the American Academy of Dermatology"},{"key":"10697_CR41","doi-asserted-by":"crossref","unstructured":"Lee, S. E., Lee, S. J., Kim, S. E., Kim, K., Cho, B., Roh, K. (2021). Intravenous allogeneic umbilical cord blood\u2013derived mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa patients. JCI Insight. ;6(2).","DOI":"10.1172\/jci.insight.143606"},{"issue":"4","key":"10697_CR42","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","volume":"126","author":"K Takahashi","year":"2006","unstructured":"Takahashi, K., & Yamanaka, S. (2006). Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell, 126(4), 663\u2013676.","journal-title":"Cell"},{"issue":"5","key":"10697_CR43","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.stem.2020.10.014","volume":"27","author":"D Hendriks","year":"2020","unstructured":"Hendriks, D., Clevers, H., & Artegiani, B. (2020). CRISPR-Cas tools and their application in genetic engineering of human stem cells and organoids. Cell stem cell, 27(5), 705\u2013731.","journal-title":"Cell stem cell"},{"issue":"5","key":"10697_CR44","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.stem.2016.04.013","volume":"18","author":"D Hockemeyer","year":"2016","unstructured":"Hockemeyer, D., & Jaenisch, R. (2016). Induced pluripotent stem cells meet genome editing. Cell stem cell, 18(5), 573\u2013586.","journal-title":"Cell stem cell"},{"key":"10697_CR45","doi-asserted-by":"crossref","unstructured":"Jack\u00f3w, J., Guo, Z., Hansen, C., Abaci, H. E., Doucet, Y. S., Shin, J. U. (2019). CRISPR\/Cas9-based targeted genome editing for correction of recessive dystrophic epidermolysis bullosa using iPS cells. Proceedings of the National Academy of Sciences. ;116(52):26846-52.","DOI":"10.1073\/pnas.1907081116"},{"key":"10697_CR46","doi-asserted-by":"crossref","unstructured":"Sasaki, M., Abe, R., Fujita, Y., Ando, S., Inokuma, D., & Shimizu, H. (1950). Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. Journal of immunology (Baltimore, Md: 2008;180(4):2581-7.","DOI":"10.4049\/jimmunol.180.4.2581"},{"issue":"8","key":"10697_CR47","doi-asserted-by":"publisher","first-page":"980","DOI":"10.2174\/22123946MTE0cNjc70","volume":"16","author":"NK Farkhad","year":"2021","unstructured":"Farkhad, N. K., Mahmoudi, A., & Mahdipour, E. (2021). How similar are human mesenchymal stem cells derived from different origins? A review of comparative studies. Current stem cell Research & Therapy, 16(8), 980\u2013993.","journal-title":"Current stem cell Research & Therapy"},{"issue":"4","key":"10697_CR48","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.4049\/jimmunol.180.4.2581","volume":"180","author":"M Sasaki","year":"2008","unstructured":"Sasaki, M., Abe, R., Fujita, Y., Ando, S., Inokuma, D., & Shimizu, H. (2008). Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. The Journal of Immunology, 180(4), 2581\u20132587.","journal-title":"The Journal of Immunology"},{"issue":"1","key":"10697_CR49","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s13287-021-02697-9","volume":"13","author":"D Bian","year":"2022","unstructured":"Bian, D., Wu, Y., Song, G., Azizi, R., & Zamani, A. (2022). The application of mesenchymal stromal cells (MSCs) and their derivative exosome in skin wound healing: A comprehensive review. Stem cell Research & Therapy, 13(1), 24.","journal-title":"Stem cell Research & Therapy"},{"issue":"4","key":"10697_CR50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.2217\/rme-2021-0076","volume":"17","author":"J Wang","year":"2022","unstructured":"Wang, J., Zhang, D., Zhu, Y., Mo, X., McHugh, P. C., & Tong, Q. (2022). Astragalus and human mesenchymal stem cells promote wound healing by mediating immunomodulatory effects through paracrine signaling. Regenerative Medicine, 17(4), 219\u2013232.","journal-title":"Regenerative Medicine"},{"issue":"10","key":"10697_CR51","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1002\/sctm.19-0241","volume":"9","author":"M Zhu","year":"2020","unstructured":"Zhu, M., Chu, Y., Shang, Q., Zheng, Z., Li, Y., Cao, L., et al. (2020). Mesenchymal stromal cells pretreated with pro-inflammatory cytokines promote skin wound healing through VEGFC-mediated angiogenesis. Stem Cells Translational Medicine, 9(10), 1218\u20131232.","journal-title":"Stem Cells Translational Medicine"},{"key":"10697_CR52","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.reth.2022.06.009","volume":"21","author":"C Liu","year":"2022","unstructured":"Liu, C., Lu, Y., Du, P., Yang, F., Guo, P., Tang, X., et al. (2022). Mesenchymal stem cells pretreated with proinflammatory cytokines accelerate skin wound healing by promoting macrophages migration and M2 polarization. Regen Ther, 21, 192\u2013200.","journal-title":"Regen Ther"},{"issue":"6","key":"10697_CR53","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1038\/leu.2011.389","volume":"26","author":"M Ratajczak","year":"2012","unstructured":"Ratajczak, M., Kucia, M., Jadczyk, T., Greco, N., Wojakowski, W., Tendera, M., et al. (2012). Pivotal role of paracrine effects in stem cell therapies in regenerative medicine: Can we translate stem cell-secreted paracrine factors and microvesicles into better therapeutic strategies? Leukemia, 26(6), 1166\u20131173.","journal-title":"Leukemia"},{"key":"10697_CR54","doi-asserted-by":"publisher","first-page":"989473","DOI":"10.1155\/2015\/989473","volume":"2015","author":"G Zheng","year":"2015","unstructured":"Zheng, G., Ge, M., Qiu, G., Shu, Q., & Xu, J. (2015). Mesenchymal stromal cells affect Disease outcomes via Macrophage polarization. Stem Cells International, 2015, 989473.","journal-title":"Stem Cells International"},{"issue":"4","key":"10697_CR55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/scrt75","volume":"2","author":"MM Duffy","year":"2011","unstructured":"Duffy, M. M., Ritter, T., Ceredig, R., & Griffin, M. D. (2011). Mesenchymal stem cell effects on T-cell effector pathways. Stem Cell Research & Therapy, 2(4), 34.","journal-title":"Stem Cell Research & Therapy"},{"key":"10697_CR56","unstructured":"Farkhad, N. K., Reihani, H., Moghadam, A. A., Moghadam, A. B., & Tavakol-Afshari, J. (2021). Are mesenchymal stem cells able to manage Cytokine Storm in COVID-19 patients? A review of recent studies. Regenerative Therapy."},{"issue":"5","key":"10697_CR57","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.3390\/cells9051157","volume":"9","author":"DH Ha","year":"2020","unstructured":"Ha, D. H., Kim, H., Lee, J., Kwon, H. H., Park, G. H., Yang, S. H., et al. (2020). Mesenchymal stem\/stromal cell-derived exosomes for immunomodulatory therapeutics and skin regeneration. Cells, 9(5), 1157.","journal-title":"Cells"},{"issue":"1","key":"10697_CR58","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1089\/scd.2019.0203","volume":"29","author":"P Weeratunga","year":"2020","unstructured":"Weeratunga, P., Shahsavari, A., Fennis, E., Wolvetang, E. J., Ovchinnikov, D. A., & Whitworth, D. J. (2020). Induced pluripotent stem cell-derived mesenchymal stem cells from the tasmanian devil (Sarcophilus harrisii) express immunomodulatory factors and a tropism toward devil facial tumor cells. Stem Cells and Development, 29(1), 25\u201337.","journal-title":"Stem Cells and Development"},{"issue":"2","key":"10697_CR59","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1002\/jbm.b.34921","volume":"110","author":"P Heydari","year":"2022","unstructured":"Heydari, P., Kharaziha, M., Varshosaz, J., & Javanmard, S. H. (2022). Current knowledge of immunomodulation strategies for chronic skin wound repair. Journal of Biomedical Materials Research Part B: Applied Biomaterials, 110(2), 265\u2013288.","journal-title":"Journal of Biomedical Materials Research Part B: Applied Biomaterials"},{"issue":"1","key":"10697_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-021-02650-w","volume":"12","author":"X Zhao","year":"2021","unstructured":"Zhao, X., Li, Q., Guo, Z., & Li, Z. (2021). Constructing a cell microenvironment with biomaterial scaffolds for stem cell therapy. Stem cell Research & Therapy, 12(1), 1\u201313.","journal-title":"Stem cell Research & Therapy"},{"issue":"8","key":"10697_CR61","doi-asserted-by":"publisher","first-page":"108","DOI":"10.3390\/bioengineering8080108","volume":"8","author":"M Abdul-Al","year":"2021","unstructured":"Abdul-Al, M., Kyeremeh, G. K., Saeinasab, M., Heidari Keshel, S., & Sefat, F. (2021). Stem cell niche microenvironment. Bioengineering, 8(8), 108.","journal-title":"Bioengineering"},{"issue":"12","key":"10697_CR62","doi-asserted-by":"publisher","first-page":"3126","DOI":"10.1038\/s41375-020-01041-z","volume":"34","author":"MZ Ratajczak","year":"2020","unstructured":"Ratajczak, M. Z., & Ratajczak, J. (2020). Extracellular microvesicles\/exosomes: Discovery, disbelief, acceptance, and the future? Leukemia, 34(12), 3126\u20133135.","journal-title":"Leukemia"},{"key":"10697_CR63","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.biochi.2018.04.007","volume":"155","author":"JD McBride","year":"2018","unstructured":"McBride, J. D., Rodriguez-Menocal, L., Candanedo, A., Guzman, W., Garcia-Contreras, M., & Badiavas, E. V. (2018). Dual mechanism of type VII collagen transfer by bone marrow mesenchymal stem cell extracellular vesicles to recessive dystrophic epidermolysis bullosa fibroblasts. Biochimie, 155, 50\u201358.","journal-title":"Biochimie"},{"key":"10697_CR64","doi-asserted-by":"publisher","first-page":"647012","DOI":"10.3389\/fcell.2021.647012","volume":"9","author":"MI Qui\u00f1ones-Vico","year":"2021","unstructured":"Qui\u00f1ones-Vico, M. I., Sanabria-De La Torre, R., S\u00e1nchez-D\u00edaz, M., Sierra-S\u00e1nchez, \u00c1., Montero-V\u00edlchez, T., Fern\u00e1ndez-Gonz\u00e1lez, A., et al. (2021). The role of exosomes derived from mesenchymal stromal cells in dermatology. Frontiers in cell and Developmental Biology, 9, 647012.","journal-title":"Frontiers in cell and Developmental Biology"},{"issue":"6","key":"10697_CR65","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jid.2018.11.036","volume":"139","author":"MP Marinkovich","year":"2019","unstructured":"Marinkovich, M. P., & Tang, J. Y. (2019). Gene therapy for epidermolysis bullosa. Journal of Investigative Dermatology, 139(6), 1221\u20131226.","journal-title":"Journal of Investigative Dermatology"},{"issue":"3","key":"10697_CR66","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/ng1743","volume":"38","author":"FJ Smith","year":"2006","unstructured":"Smith, F. J., Irvine, A. D., Terron-Kwiatkowski, A., Sandilands, A., Campbell, L. E., Zhao, Y., et al. (2006). Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nature Genetics, 38(3), 337\u2013342.","journal-title":"Nature Genetics"},{"issue":"6","key":"10697_CR67","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1086\/302672","volume":"65","author":"M Floeth","year":"1999","unstructured":"Floeth, M., & Bruckner-Tuderman, L. (1999). Digenic junctional epidermolysis bullosa: Mutations in COL17A1 and LAMB3 genes. The American Journal of Human Genetics, 65(6), 1530\u20131537.","journal-title":"The American Journal of Human Genetics"},{"key":"10697_CR68","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/bs.pmbts.2020.12.007","volume":"182","author":"T Kocher","year":"2021","unstructured":"Kocher, T., & Koller, U. (2021). Advances in gene editing strategies for epidermolysis bullosa. Progress in Molecular Biology and Translational Science, 182, 81\u2013109.","journal-title":"Progress in Molecular Biology and Translational Science"},{"key":"10697_CR69","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.omtn.2021.05.015","volume":"25","author":"T Kocher","year":"2021","unstructured":"Kocher, T., Bischof, J., Haas, S. A., March, O. P., Liemberger, B., Hainzl, S., et al. (2021). A non-viral and selection-free COL7A1 HDR approach with improved safety profile for dystrophic epidermolysis bullosa. Molecular Therapy-Nucleic Acids, 25, 237\u2013250.","journal-title":"Molecular Therapy-Nucleic Acids"},{"issue":"6","key":"10697_CR70","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/j.ymthe.2021.02.019","volume":"29","author":"J Bonafont","year":"2021","unstructured":"Bonafont, J., Menc\u00eda, A., Chac\u00f3n-Solano, E., Srifa, W., Vaidyanathan, S., Romano, R., et al. (2021). Correction of recessive dystrophic epidermolysis bullosa by homology-directed repair-mediated genome editing. Molecular Therapy, 29(6), 2008\u20132018.","journal-title":"Molecular Therapy"},{"issue":"5","key":"10697_CR71","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/j.ymthe.2019.03.007","volume":"27","author":"J Bonafont","year":"2019","unstructured":"Bonafont, J., Menc\u00eda, \u00c1., Garc\u00eda, M., Torres, R., Rodr\u00edguez, S., Carretero, M., et al. (2019). Clinically relevant correction of recessive dystrophic epidermolysis bullosa by dual sgRNA CRISPR\/Cas9-mediated gene editing. Molecular Therapy, 27(5), 986\u2013998.","journal-title":"Molecular Therapy"},{"issue":"5","key":"10697_CR72","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1172\/JCI30465","volume":"117","author":"AM Pasmooij","year":"2007","unstructured":"Pasmooij, A. M., Pas, H. H., Bolling, M. C., & Jonkman, M. F. (2007). Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3. The Journal of Clinical Investigation, 117(5), 1240\u20131248.","journal-title":"The Journal of Clinical Investigation"},{"issue":"3","key":"10697_CR73","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1046\/j.1523-1747.1999.00524.x","volume":"112","author":"VM Schoop","year":"1999","unstructured":"Schoop, V. M., Fusenig, N. E., & Mirancea, N. (1999). Epidermal organization and differentiation of HaCaT keratinocytes in organotypic coculture with human dermal fibroblasts. Journal of Investigative Dermatology, 112(3), 343\u2013353.","journal-title":"Journal of Investigative Dermatology"},{"issue":"2","key":"10697_CR74","doi-asserted-by":"publisher","first-page":"100082","DOI":"10.1016\/j.xjidi.2021.100082","volume":"2","author":"JP Smits","year":"2022","unstructured":"Smits, J. P., Meesters, L. D., Maste, B. G., Zhou, H., Zeeuwen, P. L., & van den Bogaard, E. H. (2022). CRISPR-Cas9\u2013Based genomic Engineering in keratinocytes: From technology to application. JID Innovations, 2(2), 100082.","journal-title":"JID Innovations"},{"key":"10697_CR75","doi-asserted-by":"crossref","unstructured":"Lwin, S. M., Syed, F., Di, W. L., Kadiyirire, T., Liu, L., Guy, A. (2019). Safety and early efficacy outcomes for lentiviral fibroblast gene therapy in recessive dystrophic epidermolysis bullosa. JCI Insight. ;4(11).","DOI":"10.1016\/j.jid.2019.07.288"},{"issue":"17","key":"10697_CR76","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1001\/jama.2016.15588","volume":"316","author":"Z Siprashvili","year":"2016","unstructured":"Siprashvili, Z., Nguyen, N. T., Gorell, E. S., Loutit, K., Khuu, P., Furukawa, L. K., et al. (2016). Safety and Wound outcomes following genetically corrected autologous epidermal grafts in patients with recessive Dystrophic Epidermolysis Bullosa. Jama, 316(17), 1808\u20131817.","journal-title":"Jama"},{"issue":"12","key":"10697_CR77","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1038\/nm1504","volume":"12","author":"F Mavilio","year":"2006","unstructured":"Mavilio, F., Pellegrini, G., Ferrari, S., Di Nunzio, F., Di Iorio, E., Recchia, A., et al. (2006). Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. Nature Medicine, 12(12), 1397\u20131402.","journal-title":"Nature Medicine"},{"issue":"4","key":"10697_CR78","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1038\/s41591-022-01737-y","volume":"28","author":"I Gurevich","year":"2022","unstructured":"Gurevich, I., Agarwal, P., Zhang, P., Dolorito, J. A., Oliver, S., Liu, H., et al. (2022). In vivo topical gene therapy for recessive dystrophic epidermolysis bullosa: A phase 1 and 2 trial. Nature Medicine, 28(4), 780\u2013788.","journal-title":"Nature Medicine"},{"key":"10697_CR79","doi-asserted-by":"crossref","unstructured":"Nita, M., Pliszczy\u0144ski, J., Eljaszewicz, A., Moniuszko, M., O\u0142dak, T., Wo\u017aniak, K., et al. (2021). Surgical Treatment of wounds using stem cells in Epidermolysis Bullosa (EB). IntechOpen.","DOI":"10.5772\/intechopen.97036"},{"issue":"3","key":"10697_CR80","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3390\/jfb6030547","volume":"6","author":"M Varkey","year":"2015","unstructured":"Varkey, M., Ding, J., & Tredget, E. E. (2015). Advances in skin substitutes-potential of tissue Engineered skin for Facilitating Anti-fibrotic Healing. Journal of Functional Biomaterials, 6(3), 547\u2013563.","journal-title":"Journal of Functional Biomaterials"},{"issue":"2","key":"10697_CR81","first-page":"118","volume":"27","author":"D Zeydari","year":"2024","unstructured":"Zeydari, D., Karimi, E., & Saburi, E. (2024). Synthesis of bone biocompatible implants using human adipose-derived mesenchymal stem cells (hADMSCs) and PCL\/laminin scaffold substrate. Iranian Journal of Basic Medical Sciences, 27(2), 118\u2013194.","journal-title":"Iranian Journal of Basic Medical Sciences"},{"issue":"1","key":"10697_CR82","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1080\/00914037.2022.2124253","volume":"73","author":"F Daliri Shadmehri","year":"2024","unstructured":"Daliri Shadmehri, F., Karimi, E., & Saburi, E. (2024). Electrospun PCL\/fibrin scaffold as a bone implant improved the differentiation of human adipose-derived mesenchymal stem cells into osteo-like cells. International Journal of Polymeric Materials and Polymeric Biomaterials, 73(1), 71\u201378.","journal-title":"International Journal of Polymeric Materials and Polymeric Biomaterials"},{"key":"10697_CR83","doi-asserted-by":"crossref","unstructured":"Wang, C. Y., Hong, P. D., Wang, D. H., Cherng, J. H., Chang, S. J., Liu, C. C. (2020). Polymeric gelatin scaffolds affect mesenchymal stem cell differentiation and its diverse applications in tissue Engineering. International Journal of Molecular Sciences. ;21(22).","DOI":"10.3390\/ijms21228632"},{"issue":"1","key":"10697_CR84","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/adhm.201200197","volume":"2","author":"JJ Rice","year":"2013","unstructured":"Rice, J. J., Martino, M. M., De Laporte, L., Tortelli, F., Briquez, P. S., & Hubbell, J. A. (2013). Engineering the regenerative microenvironment with biomaterials. Advanced Healthcare Materials, 2(1), 57\u201371.","journal-title":"Advanced Healthcare Materials"},{"key":"10697_CR85","doi-asserted-by":"publisher","first-page":"901661","DOI":"10.3389\/fcell.2022.901661","volume":"10","author":"IS Hong","year":"2022","unstructured":"Hong, I. S. (2022). Enhancing stem cell-based therapeutic potential by combining various Bioengineering technologies. Front Cell Dev Biol, 10, 901661.","journal-title":"Front Cell Dev Biol"},{"key":"10697_CR86","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.reth.2021.01.007","volume":"16","author":"X Su","year":"2021","unstructured":"Su, X., Wang, T., & Guo, S. (2021). Applications of 3D printed bone tissue engineering scaffolds in the stem cell field. Regen Ther, 16, 63\u201372.","journal-title":"Regen Ther"},{"issue":"24","key":"10697_CR87","doi-asserted-by":"publisher","first-page":"3455","DOI":"10.2174\/1381612823666170526094606","volume":"23","author":"N Bhardwaj","year":"2017","unstructured":"Bhardwaj, N., Chouhan, D., & Mandal, B. B. (2017). Tissue Engineered skin and Wound Healing: Current strategies and future directions. Current Pharmaceutical Design, 23(24), 3455\u20133482.","journal-title":"Current Pharmaceutical Design"},{"issue":"1","key":"10697_CR88","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1111\/bjd.16338","volume":"179","author":"H Moravvej","year":"2018","unstructured":"Moravvej, H., Abdollahimajd, F., Naseh, M., Piravar, Z., Abolhasani, E., Mozafari, N., et al. (2018). Cultured allogeneic fibroblast injection vs. fibroblasts cultured on amniotic membrane scaffold for dystrophic epidermolysis bullosa treatment. British Journal of Dermatology, 179(1), 72\u201379.","journal-title":"British Journal of Dermatology"},{"key":"10697_CR89","doi-asserted-by":"crossref","unstructured":"Pliszczy\u0144ski, J., Nita, M., Kowalewski, C., Wo\u017aniak, K., Eljaszewicz, A., Moniuszko, M., et al. (Eds.). (2020). Transplantation of a new biological product in rare diseases, such as epidermolysis bullosa: Response and clinical outcome. Transplant Proc.","DOI":"10.1016\/j.transproceed.2020.02.119"},{"key":"10697_CR90","doi-asserted-by":"crossref","unstructured":"Eichstadt, S., Barriga, M., Ponakala, A., Teng, C., Nguyen, N. T., Siprashvili, Z. (2019). Phase 1\/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa. JCI Insight. ;4(19).","DOI":"10.1172\/jci.insight.130554"},{"issue":"2","key":"10697_CR91","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1111\/pde.12492","volume":"32","author":"ES Gorell","year":"2015","unstructured":"Gorell, E. S., Leung, T. H., Khuu, P., & Lane, A. T. (2015). Purified type I collagen wound matrix improves chronic wound healing in patients with recessive dystrophic epidermolysis bullosa. Pediatric Dermatology, 32(2), 220\u2013225.","journal-title":"Pediatric Dermatology"}],"container-title":["Stem Cell Reviews and Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-024-10697-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12015-024-10697-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12015-024-10697-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T02:32:00Z","timestamp":1719973920000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12015-024-10697-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,2]]},"references-count":91,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["10697"],"URL":"https:\/\/doi.org\/10.1007\/s12015-024-10697-4","relation":{},"ISSN":["2629-3269","2629-3277"],"issn-type":[{"value":"2629-3269","type":"print"},{"value":"2629-3277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,2]]},"assertion":[{"value":"12 February 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 March 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent to Participate"}},{"value":"All authors consent to publish the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}